Results 161 to 170 of about 41,311 (257)

First‐in‐Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP1617, a Cathepsin‐S Inhibitor, in Healthy Adult Subjects

open access: yesClinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT ASP1617 is a novel, highly selective inhibitor of cathepsin‐S, an important protease for antigen peptide loading onto major histocompatibility complex class II molecules. Preclinically, ASP1617 prevented progression of lupus‐like glomerulonephritis in an NZB/W F1 mouse model of systemic lupus erythematosus.
Tomoki Kojima   +9 more
wiley   +1 more source

Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study [PDF]

open access: bronze, 2009
Till Keller   +13 more
openalex   +1 more source

Potential new biomarkers in pig saliva for differentiating between the effects of different conditions of mixing and density at pre-slaughter: A preliminary proteomicstudy. [PDF]

open access: yesAnim Welf
Botía M   +12 more
europepmc   +1 more source

Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. [PDF]

open access: bronze, 1999
Chang-Goo Huh   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy